Anticoagulant reversal agents

Anticoagulant reversal agents

Drug monograph · NCLEX study reference
Trade names	Praxbind, Andexxa
Therapeutic class	Antidote (anticoagulant reversal)
Pharmacologic class	Vitamin K, heparin antagonist, monoclonal antibody fragment, modified factor Xa
Onset / peak / duration	Protamine and idarucizumab and andexanet act quickly; vitamin K takes hours (use plasma or concentrate for urgent warfarin reversal).
Half-life / level	Varies; monitor coagulation and bleeding.
Routes	PO (oral), IV, SubQ
High-alert (ISMP)	No
Black box warning	Yes (see Safety)
Antidote / reversal	Not applicable.
Pregnancy / lactation	Used in emergencies.

Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and must be verified against current manufacturer labeling before clinical use. This is educational content, not prescribing guidance.

Anticoagulant reversal agents (brand names Praxbind, Andexxa) — Antidote (anticoagulant reversal); Vitamin K, heparin antagonist, monoclonal antibody fragment, modified factor Xa.

Identification

• Therapeutic class: Antidote (anticoagulant reversal).
• Pharmacologic class: Vitamin K, heparin antagonist, monoclonal antibody fragment, modified factor Xa.

Pharmacology

• Mechanism of action: Vitamin K restores clotting factor synthesis (reverses warfarin); protamine binds and neutralizes heparin; idarucizumab binds dabigatran; andexanet binds and sequesters factor Xa inhibitors.
• Onset / peak / duration: Protamine and idarucizumab and andexanet act quickly; vitamin K takes hours (use plasma or concentrate for urgent warfarin reversal).
• Half-life / therapeutic level: Varies; monitor coagulation and bleeding.

Clinical use

• Indications: Reversal of the respective anticoagulant for serious bleeding or urgent surgery.
• Usual dose, route, frequency: Vitamin K PO, IV, or SubQ; protamine slow IV; idarucizumab and andexanet IV per protocol.
• Maximum dose / adjustments: Protamine dosed to the heparin given; give IV vitamin K slowly (anaphylaxis risk).

Safety

• Contraindications: Hypersensitivity; protamine caution with fish allergy and prior protamine exposure.
• Black box warning: Andexanet alfa carries a boxed warning for thromboembolic events, ischemic events, cardiac arrest, and sudden death.
• Interactions: Re-anticoagulation may be needed after reversal.
• Pregnancy / lactation: Used in emergencies.
• High-alert: No.

Adverse effects

• Common side effects: Protamine hypotension and flushing with rapid infusion; vitamin K injection-site reactions.
• Serious effects to report: Protamine anaphylaxis and severe hypotension, rebound anticoagulation, thrombosis (andexanet).
• Antidote / reversal: Not applicable.

Nursing process

• Assessment before administration: Which anticoagulant, bleeding severity, coagulation labs, allergy history.
• Interventions during therapy: Give protamine slowly with monitoring; recheck coagulation; watch for rebound bleeding and for new clotting.
• Monitor: Coagulation labs, bleeding, blood pressure, signs of thrombosis.
• Evaluation / expected outcome: Controlled bleeding with restored hemostasis.

Patient teaching

• Patient teaching: Emergency therapy; ongoing anticoagulation plan will be reassessed.
• Notify provider if: Re-bleeding or new clot symptoms (monitored setting).
• Administration tips: Match the reversal agent to the anticoagulant; protamine slow IV.